TRVI: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Chronic cough in ipf clinical trial expense	6,743	-
Refractory chronic cough clinical trial expense	1,371	-
Clinical trial material	5,622	-
Other clinical trials and studies	1,344	-
Other clinical development expenses	4,827	-
Employee compensation (excluding stock compensation expense)	8,816	-
Stock-based compensation expense	3,835	-
Other segment items	6,518	-
Interest income, net	4,633	-
Net loss	-34,443	-22,641
Stock-based compensation	3,835	2,592
Operating lease right-of-use assets	330	222
Depreciation and amortization	113	75
Accretion of available-for-sale marketable securities, net	1,076	778
Prepaid expenses and other current assets	1,636	1,606
Accrued expenses and other liabilities	-860	-1,003
Accounts payable	-721	-439
Net cash used in operating activities	-34,458	-23,578
Proceeds from maturities of available-for-sale marketable securities	52,779	32,095
Purchases of available-for-sale marketable securities	116,266	44,656
Purchases of property, equipment and leasehold improvements	12	0
Net cash (used in) provided by investing activities	-63,499	-12,561
Proceeds from offering of common stock, net of commissions	108,154	108,154
Proceeds from exercises of warrants	10,757	10,757
Proceeds from exercises of stock options	1,854	731
Proceeds from disgorgement of beneficial owner's short-swing profits	725	-
Proceeds from employee stock purchase plan	59	59
Payments of offering costs	809	590
Payments of finance lease	11	11
Proceeds from at-the-market sales agreement, net of commissions and allocated fees	0	0
Net cash provided by financing activities	120,729	119,100
Net increase (decrease) in cash and cash equivalents	22,772	82,961
Cash and cash equivalents at beginning of period	34,097	-
Cash and cash equivalents at end of period	56,869	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

TRVI: the cashflow